MedicalResearch.com Interview with: Emily E. Groopman, B.A Departments of Medicine Hammer Health Sciences, and the Department of Epidemiology Columbia University,...
While Mohs surgery is considered the gold standard when it comes to nonmelanoma skin cancer and excision for melanoma, there are other treatment options.
MedicalResearch.comInterview with: Zhaohui Gu, PhDPostdoctoral Research Associate St. Jude Children’s Research Hospital, TN MedicalResearch.com: What is the background for this study? What...
The preliminary results suggest that CD20-TCB monotherapy have promising clinical activity and may induce durable complete responses in patients with late-line R/R aggressive Non-Hodgkin’s Lymphoma.
MedicalResearch.com Interview with: Charles G. Mullighan, MBBS (Hons), MSc, MD Member, St. Jude Faculty Co-Leader, Hematological Malignancies Program Medical Director, St. Jude...
MedicalResearch.com Interview with: Dr. Alan List MD President and Chief Executive Officer Moffitt Cancer Center Tampa, FL MedicalResearch.com: What is...
DaraVMP is a new standard of care for ND multiple myeloma not eligible for transplant that can be potentially affordable in many countries due to the fact that bortezomib, melphalan and prednisone is not an expensive combination so dara would be the only new and more expensive agent
Response: The CENTAURUS study was a randomized phase II trial evaluating 3 different dosing schedules of daratumumab for the treatment of smoldering multiple myeloma at intermediate to high risk of progression to active disease
MedicalResearch.com Interview with: Ricardo Alvarez MD MSc Medical Director of the Breast Cancer Center Director of Cancer Research Cancer Treatment...
MedicalResearch.com Interview with: Sean O’Quinn MPH Director, Patient Reported Outcomes AstraZeneca MedicalResearch.com: What is the background for this study? How...
Despite the advances in knowledge around HIV transmission, people living with HIV still face considerable stigma and discrimination as a result of their diagnosis.
MedicalResearch.com Interview with: Sooyeon Suh, PhD Department of Psychology Sungshin University Seoul, Republic of Korea MedicalResearch.com: What is the background...
We are also partnering with the Autism Treatment Network to investigate how saliva RNA profiles respond to minocycline therapy in children with autism enrolled in their clinical trial.
MedicalResearch.com Interview with: Andrea Hahn, M.D., MS Infectious disease specialist and lead study author Children’s National Health System MedicalResearch.com: What...
The method of head and neck cancer care delivery is potentially modifiable through targeted interventions and thus represents an important target that can be manipulated to improve survival for head and neck cancer patients.
Our study highlights the unmet need in CKD patients and the importance to keep them on guideline-recommended RAASi therapies to optimize patient outcomes.
In the trials, Dupixent reduced severe asthma exacerbations, improved lung function, reduced oral corticosteroid use and improved measures of health-related quality of life.
MedicalResearch.com Interview with: Dr Mattias Ivarsson PhD CEO, Inositec, co-author of data MedicalResearch.com: What is the background for this study?...
This randomized clinical trial first supplied the evidences in multiple parameters that erlotinib used before surgery could improve survival with free relapse.
MedicalResearch.com Interview with: Michelle Hoffman Brown Associate Principal Scientist Merck MedicalResearch.com: What is the background for this study? What are...
MedicalResearch.com Interview with: Luca A. Lotta, MD, PhD Senior Clinical Investigator MRC Epidemiology Unit University of Cambridge MedicalResearch.com: What is...
MedicalResearch.com Interview with: Chyke Doubeni, M.D., M.P.H. Harrison McCrea Dickson, M.D. and Clifford C. Baker, M.D. Presidential Professor Associate Professor...
MedicalResearch.com Interview with: Han Eol Lee Ph.D. Flexible and Nanobio Device Lab. Department of Materials Science and Engineering KAIST MedicalResearch.com: What...
This does not mean that doctor will be replaced any time soon, but when used in clinical practice it can - at the very least - help pathologists reduce human error.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.AcceptRejectRead More
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are as essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.